As our previous report showed that oligoclonal, Ph-chromosome negative lymphocytes are common in CML patients at diagnosis and during TKI therapy, we hypothesized that these cells could also be found in IFN-α treated patients. This evidence concerns the gene IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive.